This session brings together experts in oncology, surgery, and radiology to address advancements in the diagnosis and management of liver-related cancers and metastases. The program is designed to provide a multidisciplinary perspective on hepatocellular carcinoma (HCC) and colorectal liver metastases, highlighting the roles of early detection, precise imaging, effective surgical planning and collaborative decision-making.
Participants will gain insights into the latest diagnostic methods and therapeutic strategies for HCC and liver metastases and their impact on patient outcomes.
Essential information of Primovist is located at Bayer booth.
PP-PRIM-ALL-0552-1 11.2024
Advances in early diagnosis and management of HCC: an oncologist´s perspective
- Identify emerging diagnostic techniques for early detection of hepatocellular carcinoma (HCC).
- Discuss recent advancements in therapeutic options and management strategies for HCC.
- Understand the oncologist's perspective on integrating early diagnosis with personalized treatment pathways for improved patient outcomes.
What does your surgeon need? Optimal imaging before surgical intervention of patients with colorectal liver metastases
- Define key imaging requirements and pre-surgical considerations for colorectal liver metastases.
- Explain how optimal imaging can support surgical planning and improve patient outcomes.
- Analyze the surgeon’s perspective on collaboration with radiologists to enhance imaging accuracy and procedural success.
Improving Gadoxetic Acid-enhanced MRI: Key Insights for the Radiologist
- Review recent developments in Gadoxetic Acid-enhanced MRI for liver imaging.
- Explore case studies to understand the practical applications of Gadoxetic Acid-enhanced MRI in clinical scenarios.
- Facilitate a collaborative discussion among oncologists, surgeons, and radiologists to improve interdisciplinary understanding and diagnostic accuracy for liver pathologies, by introducing a panel case discussion.
Case study panel discussion